One-liner#

Evaluate and manage anxiety disorders in primary care using validated screening tools and first-line treatments (SSRIs, SNRIs, psychotherapy), while distinguishing from medical causes and knowing when to refer.

Quick nav#

Red flags / send to ED#

  • Panic attack with chest pain, dyspnea, or syncope in patient with cardiac risk factors → rule out ACS, PE, arrhythmia
  • Severe agitation with inability to be redirected → may need acute psychiatric intervention
  • Active suicidal ideation with plan/intent → ED for psychiatric evaluation
  • Symptoms of serotonin syndrome (if on serotonergic medications): fever, rigidity, hyperreflexia, altered mental status

Urgent (not ED, but expedited):

  • Panic attacks so frequent patient cannot function
  • Severe agoraphobia (housebound)
  • Anxiety with active substance withdrawal

Key history#

GAD-7 (administer at every visit):

  • Score 0-4: minimal
  • Score 5-9: mild
  • Score 10-14: moderate
  • Score 15-21: severe

Core symptoms of generalized anxiety:

  • Excessive worry about multiple domains (work, health, family, finances)
  • Difficulty controlling worry
  • Duration ≥6 months
  • Associated symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance

Panic attack symptoms:

  • Sudden onset, peaks within minutes
  • Palpitations, sweating, trembling
  • Shortness of breath, chest pain
  • Nausea, dizziness, paresthesias
  • Fear of losing control or dying
  • Derealization/depersonalization

Pattern recognition questions:

  • “What triggers your anxiety?” (situational vs generalized)
  • “Do you have sudden episodes of intense fear?” (panic)
  • “Do you avoid certain situations?” (phobias, agoraphobia)
  • “Are you worried about being judged by others?” (social anxiety)
  • “Do you have intrusive thoughts you can’t control?” (OCD—refer to psychiatry)
  • “Have you experienced a traumatic event?” (PTSD—often needs specialty care)

Functional impact:

  • Work/school performance
  • Relationships and social activities
  • Avoidance behaviors
  • Sleep quality

Rule out medical causes:

  • Hyperthyroidism
  • Cardiac arrhythmias
  • Pheochromocytoma (rare but classic)
  • Hypoglycemia
  • Medication/substance-induced (caffeine, stimulants, decongestants, steroids, thyroid hormone)
  • Substance withdrawal (alcohol, benzodiazepines, opioids)

Substance use screen:

  • Caffeine intake (often overlooked)
  • Alcohol (can cause/worsen anxiety; withdrawal mimics panic)
  • Cannabis (can trigger panic)
  • Stimulants (cocaine, amphetamines, ADHD medications)

Comorbidities:

  • Depression (60%+ comorbid)
  • Other anxiety disorders
  • Substance use disorders
  • Chronic pain

Focused exam#

Vital signs:

  • Tachycardia (anxiety vs hyperthyroidism vs arrhythmia)
  • Elevated BP (anxiety vs pheochromocytoma)
  • Tremor

Physical exam (to rule out medical causes):

  • Thyroid: goiter, nodules
  • Cardiac: irregular rhythm, murmurs
  • Neurologic: tremor, hyperreflexia (hyperthyroidism)

Mental status exam:

  • Appearance: restless, fidgeting, tense
  • Behavior: hypervigilant, easily startled
  • Speech: rapid, pressured
  • Mood: “anxious,” “nervous,” “on edge”
  • Affect: anxious, tense
  • Thought content: worry, catastrophizing, fear
  • No psychotic symptoms (if present, consider other diagnoses)

Differential (quick pattern recognition)#

Common/likely (outpatient)#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Generalized anxiety disorder“Worry all the time,” “can’t turn off my brain,” “always stressed”Excessive worry about multiple things; ≥6 months; muscle tension, poor sleepTense, restless; normal vitalsGAD-7; start SSRI + consider therapy referral
Panic disorder“Heart racing out of nowhere,” “thought I was dying,” “can’t breathe”Recurrent unexpected panic attacks; fear of next attack; avoidanceMay be normal between attacks; tachycardia during attackRule out cardiac if first presentation; SSRI first-line
Social anxiety disorder“Terrified of speaking up,” “avoid parties,” “people are judging me”Fear of social situations; avoidance; onset often in teensMay appear shy, avoid eye contactSSRI or SNRI; therapy (CBT, exposure)
Specific phobia“Terrified of [flying/needles/heights],” “avoid it completely”Intense fear of specific object/situation; immediate anxiety responseNormal unless exposed to triggerExposure therapy; benzos PRN for rare exposures (flying)
Adjustment disorder with anxiety“Since [event] I can’t stop worrying”Clear stressor; <6 months; less pervasiveAnxiety focused on stressorSupportive counseling; usually self-limited
Anxiety secondary to medical condition“Jittery,” “heart racing,” “can’t sit still”Hyperthyroidism, arrhythmia, medication effectThyroid enlargement; irregular pulse; tremorTSH, ECG; treat underlying cause

Can’t-miss / urgent#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Panic attack vs ACS/PE“Chest pain,” “can’t breathe,” “thought I was having a heart attack”Cardiac risk factors; atypical features; first episodeAbnormal vitals; cardiac findingsIf any doubt, send to ED for cardiac workup
Hyperthyroidism“Anxious and losing weight,” “heart racing,” “sweating”Weight loss, heat intolerance, tremor, palpitationsTachycardia; tremor; goiter; lid lagTSH (will be low); refer to endo if confirmed
Substance withdrawal“Shaky,” “sweating,” “feel like I’m going to die”Recent cessation of alcohol, benzos, opioidsTremor, diaphoresis, tachycardia, hypertensionAssess severity; may need medically supervised detox
Pheochromocytoma“Episodes of racing heart, sweating, headache”Paroxysmal HTN, headache, diaphoresis, palpitationsHypertension (may be episodic)24-hour urine catecholamines/metanephrines; rare but classic
OCD“Can’t stop the thoughts,” “have to do things a certain way”Intrusive thoughts + compulsive behaviors; time-consuming; distressingMay appear anxious; may have ritualsRefer to psychiatry; SSRIs at higher doses
PTSD“Since [trauma] I can’t stop thinking about it,” “nightmares”Trauma history; re-experiencing, avoidance, hyperarousalHypervigilant; exaggerated startleRefer to trauma-informed therapy; SSRI can help

Workup#

First-line (for new anxiety presentation):

TestRationale
TSHRule out hyperthyroidism
CBCBaseline; rule out anemia contributing to symptoms
BMPBaseline before medications

Consider based on presentation:

TestWhen to order
ECGPalpitations; cardiac risk factors; before starting medications that affect QT
Urine drug screenSuspected substance use
Caffeine diaryOften overlooked contributor

When NOT to order extensive workup:

  • Classic GAD or panic disorder presentation
  • No red flags for medical cause
  • Young, healthy patient with clear psychosocial stressors
  • Do NOT order brain imaging for anxiety without focal neurologic findings

Initial management#

Mild anxiety (GAD-7 5-9):

  • Psychotherapy (CBT) may be sufficient
  • Lifestyle: limit caffeine, regular exercise, sleep hygiene
  • Close follow-up

Moderate to severe anxiety (GAD-7 ≥10):

  • Medication recommended
  • SSRI or SNRI first-line
  • Combine with psychotherapy for best outcomes

Key principles:

  • SSRIs/SNRIs take 4-6 weeks for full effect
  • Start low (anxious patients sensitive to activation)
  • Warn about initial worsening before improvement
  • Avoid benzodiazepines as first-line (dependence, cognitive effects, falls in elderly)

Management by diagnosis#

Generalized anxiety disorder#

Education:

  • GAD is a medical condition, not a character flaw
  • Treatment is effective for most people
  • Medications take 4-6 weeks to work fully
  • Therapy (CBT) is as effective as medication and has lasting benefits

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
SertralineStart 25 mg daily; target 50-200 mgMAOIsNone routine$Good first choice; start low in anxious patients
EscitalopramStart 5-10 mg daily; target 10-20 mgMAOIs; QT prolongationECG if cardiac history$Well-tolerated; max 10 mg if >65
Venlafaxine XRStart 37.5 mg daily; target 75-225 mgMAOIs; uncontrolled HTNBP at higher doses$SNRI; good if comorbid pain; discontinuation syndrome
DuloxetineStart 30 mg daily; target 60-120 mgMAOIs; hepatic impairmentLFTs if concerns$$SNRI; good for comorbid pain
BuspironeStart 5 mg TID; target 15-30 mg/day in divided dosesMAOIsNone$Non-sedating; no dependence; takes 2-4 weeks; less effective than SSRIs

Benzodiazepines—use with caution:

DrugDoseContraindicationsMonitoringCostNotes
Lorazepam0.5-1 mg PRN (max 2-3x/week)Substance use history; elderly; respiratory diseaseSigns of dependence$Short-acting; for acute anxiety only; avoid daily use
Clonazepam0.25-0.5 mg BIDSame as aboveSame$Longer-acting; higher dependence risk; avoid if possible

When to use benzodiazepines:

  • Bridge therapy while waiting for SSRI to work (limit to 2-4 weeks)
  • Infrequent, predictable situational anxiety (e.g., flying 2x/year)
  • NOT for daily, long-term use in primary care

When NOT to use benzodiazepines:

  • History of substance use disorder
  • Elderly (falls, cognitive impairment—Beers criteria)
  • Concurrent opioid use
  • As monotherapy for GAD or panic disorder

Alternative for patients who cannot take SSRIs or benzos:

DrugDoseContraindicationsMonitoringCostNotes
Hydroxyzine25-50 mg TID-QID PRN or scheduledProlonged QTECG if cardiac history$Antihistamine; sedating; no dependence; good for elderly if tolerated

Pregnancy/breastfeeding:

  • Untreated anxiety carries risks; weigh benefits vs risks
  • SSRIs: sertraline preferred (most safety data)
  • Benzodiazepines: avoid if possible; if used, lowest dose, shortest duration
  • Buspirone: limited data but appears safe
  • Hydroxyzine: avoid in first trimester (limited data)
  • Refer to psychiatry or MFM for complex cases

Elderly considerations:

  • Start SSRIs at half dose
  • Escitalopram max 10 mg if >65
  • AVOID benzodiazepines (Beers criteria—falls, cognitive impairment, paradoxical agitation)
  • Buspirone or hydroxyzine may be safer alternatives
  • Monitor for hyponatremia with SSRIs

Follow-up: 2-4 weeks after starting medication; then monthly until stable.


Panic disorder#

Education:

  • Panic attacks are not dangerous (feel terrible but won’t kill you)
  • The fear of panic attacks often drives avoidance and worsens the condition
  • Treatment is very effective
  • Goal: reduce frequency/severity of attacks AND reduce avoidance

Treatment:

  • SSRI/SNRI first-line (same medications as GAD)
  • Start at LOWER doses than for depression (anxious patients sensitive)
  • CBT with interoceptive exposure highly effective
DrugDoseContraindicationsMonitoringCostNotes
SertralineStart 12.5-25 mg daily; target 50-200 mgMAOIsNone$Start very low; increase slowly
ParoxetineStart 10 mg daily; target 20-60 mgMAOIsNone$FDA-approved for panic; more sedating; weight gain; discontinuation syndrome
Venlafaxine XRStart 37.5 mg daily; target 75-225 mgMAOIs; uncontrolled HTNBP$SNRI option

For acute panic attacks (patient education):

  • Breathing techniques: slow, diaphragmatic breathing
  • Grounding techniques: 5-4-3-2-1 senses exercise
  • Remind self: “This is a panic attack. It will pass. I am not dying.”
  • PRN benzodiazepine only if attacks infrequent and no substance use history

Follow-up: 2 weeks initially; then monthly until stable.


Social anxiety disorder#

Education:

  • Very common; often starts in adolescence
  • Not just “shyness”—causes significant impairment
  • Treatment helps most people

Treatment:

  • SSRI/SNRI first-line
  • CBT with exposure therapy highly effective
  • Beta-blockers for performance-only anxiety (not generalized social anxiety)
DrugDoseContraindicationsMonitoringCostNotes
SertralineStart 25 mg daily; target 50-200 mgMAOIsNone$First-line
ParoxetineStart 10 mg daily; target 20-60 mgMAOIsNone$FDA-approved; sedating
Venlafaxine XRStart 37.5 mg daily; target 75-225 mgMAOIs; uncontrolled HTNBP$SNRI option
Propranolol10-40 mg PRN 30-60 min before performanceAsthma; bradycardia; heart blockHR, BP$Performance anxiety ONLY; not for generalized social anxiety

Follow-up: Monthly until stable.


Specific phobias#

Education:

  • Exposure therapy is the treatment of choice
  • Medications are not first-line
  • Avoidance maintains the phobia

Treatment:

  • Refer for CBT with exposure therapy
  • PRN benzodiazepine reasonable for rare, unavoidable exposures (e.g., MRI, dental procedure, flying 1-2x/year)

Follow-up: As needed; therapy-driven.


Anxiety with comorbid depression#

Education:

  • Very common combination (60%+)
  • Both need treatment
  • SSRIs treat both

Treatment:

  • SSRI first-line (treats both conditions)
  • Start low (anxious patients sensitive)
  • Prioritize safety assessment (depression + anxiety increases suicide risk)

Follow-up: 2 weeks initially; close monitoring.

Follow-up#

Initial treatment:

  • 2-4 weeks after starting medication (tolerability, early response)
  • Monthly until stable

Maintenance:

  • Every 3 months once stable
  • GAD-7 at every visit
  • Assess for side effects, adherence

Duration of treatment:

  • Minimum 12 months after remission
  • Many patients benefit from long-term maintenance
  • Taper slowly if discontinuing (over weeks to months)

Return precautions:

  • Worsening anxiety or panic attacks
  • New or worsening depression
  • Suicidal thoughts
  • Side effects that are intolerable
  • Symptoms not improving after 6-8 weeks

When to refer to psychiatry:

  • Failed 2+ adequate medication trials
  • Comorbid bipolar disorder or psychosis
  • Severe OCD or PTSD
  • Complex diagnostic picture
  • Patient preference

Patient instructions#

  • Anxiety disorders are real medical conditions. Treatment works for most people.
  • The medication takes 4-6 weeks to work fully. You may feel a bit more anxious at first—this usually passes.
  • Take your medication every day, even when you feel better. Don’t stop suddenly.
  • Limit caffeine (coffee, energy drinks, soda)—it can make anxiety worse.
  • Regular exercise, good sleep, and relaxation techniques all help.
  • Therapy (especially CBT) is very effective and teaches skills that last.
  • Call us if your anxiety gets much worse, you have thoughts of hurting yourself, or the medication causes problems you can’t tolerate.

Smartphrase snippets#

.ANXIETYGAD GAD-7 score [X] consistent with [mild/moderate/severe] generalized anxiety disorder. Safety assessment negative. TSH normal. Starting [sertraline 25 mg / escitalopram 5 mg] daily. Discussed that medication takes 4-6 weeks for full effect and may cause initial activation. Therapy referral offered. Caffeine reduction discussed. Follow-up in 2-4 weeks. Return precautions reviewed.

.ANXIETYPANIC Panic disorder with [frequency] panic attacks. No cardiac red flags; [ECG normal if done]. Safety assessment negative. Starting [sertraline 12.5 mg] daily with slow titration. Discussed nature of panic attacks (not dangerous, will pass). Breathing techniques reviewed. Therapy referral for CBT with interoceptive exposure. Follow-up in 2 weeks.

.ANXIETYFOLLOWUP Anxiety follow-up. GAD-7 today: [X] (previous: [Y]). [Improved / stable / worsened]. Current medication: [drug, dose]. [Tolerating well / side effects: X]. Plan: [continue current regimen / increase dose / add therapy / switch medication / refer to psychiatry]. Follow-up in [timeframe].